Lite Strategy Inc.
LITS | NASDAQ
$1.28
+$0.15 (+13.27%)
At close: Sep 21, 2026, 4:00 PM ET
$1.29
+$0.01 (+0.78%)
Pre-market:
Sep 22, 2026, 8:37 AM ET
+13.27%
(1D)Rating
Updated: Sep 12, 2026Key Statistics
Market Data
Market Cap $43.55M
1D Range
1.08 1.33
52W Range
0.69 2.97
Valuation (TTM)
PE -0.21
PB 0.77
EV/EBITDA -2.85
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target N/A
Cash Flow
FCF Yield -23.9%
SBC Adj. FCF Yield -24.8%
SBC Impact -3.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -64.2% |
N/A
Dil EPS 3Y | 5Y 79.7% |
N/A
FCF 3Y | 5Y 38.4% |
N/A
Returns
ROA -105.2%
ROE -90.8%
ROIC -22.4%
Financial Health
Net Cash
$7.54M
Current Ratio 11.53
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was p...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Dec 17, 2003
Website www.litestrategy.com
Fiscal Year n/a
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove LITS